Advertisement

Topics

PaxVax, Inc. Company Profile

12:11 EDT 22nd March 2019 | BioPortfolio

PaxVax is a privately held company committed to developing better vaccines to better the world. Established in 2007, PaxVax has a clinical-stage product portfolio, including a cholera vaccine entering Phase 3 and a pandemic H5N1 influenza vaccine entering Phase 2. The company also has vaccines in development for HIV and anthrax under R&D contracts with NIH. The company’s proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target any viral or bacterial protein antigen. The company's vaccine candidates are designed to be easier to manufacture, store, distribute, administer and deliver across the globe than conventional injectable vaccines while enhancing the desired immune response to the vaccine antigens. The company’s offices are headquartered in Menlo Park, Calif., and the R&D laboratories and licensed GMP production facility are based in San Diego, Calif.


News Articles [6 Associated News Articles listed on BioPortfolio]

ORAL TYPHOID VACCINE NOW OFFERS THREE YEARS DURATION OF PROTECTION FOR TRAVELLERS

Vivotif (Salmonella enterica serovar Typhi) – the only oral vaccine for typhoid fever – has been given a revised licence acknowledging that it gives three years of protection. The u...

Applied Clinical Trials Publishes First Head to Head Comparison of Clinical Trial Oversight Methods

Applied Clinical Trials publishes first head to head comparison of clinical trial oversight methods. The MANA Method proved to be superior to the traditional source document verification (SDV) approac...

Typhoid Fever Vaccines Market to Surpass US$ 554.4 Million by 2026 – Coherent Market Insights

According to Coherent Market Insights, the Typhoid fever vaccines market was valued at US$ 225.0 million in 2018, and is projected to exhibit a CAGR of 11.9% over the forecast per...

Global Oral Cholera Vaccine Market Status and Outlook 20182025 [Report Updated: 13082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...

Global Cholera Vaccine Oral Route Market Status and Outlook 20182025 [Report Updated: 16082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...

Global Typhoid Vaccine Market Status and Outlook 20182025 [Report Updated: 12082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

PaxVax Inc.

PaxVax is a privately held specialty vaccine company founded in 2007. PaxVax is focused on traveler vaccines with an emerging pipeline in biodefense coupled with a social mission ...

PaxVax Inc

PaxVax is a privately held company established in 2007 to develop and commercialize innovative vaccines against infectious diseases. PaxVax has a clinical-stage product portfolio,...

PaxVax, Inc.

PaxVax is a privately held company committed to developing better vaccines to better the world. Established in 2007, PaxVax has a clinical-stage product portfolio, including a cho...

PaxVax Corporation

PaxVax is a privately held company established in 2007 to develop and commercialize innovative and socially responsible vaccines against infectious diseases. PaxVax has a clinical...

More Information about "PaxVax, Inc." on BioPortfolio

We have published hundreds of PaxVax, Inc. news stories on BioPortfolio along with dozens of PaxVax, Inc. Clinical Trials and PubMed Articles about PaxVax, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PaxVax, Inc. Companies in our database. You can also find out about relevant PaxVax, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Vaccines
A vaccine is any preparation intended to produce immunity to a disease by stimulating the production of antibodies. It creates immunity but does not cause the disease. There are several differnt types of vaccine avalable; Killed microorganisms; which s...

Influenza
Influenza or 'flu' is a respiratory illness associated with infection by influenza virus. Symptoms frequently include headache, fever, cough, sore throat, aching muscles and joints. There is a wide spectrum of severity of illness ranging from min...


Corporate Database Quicklinks



Searches Linking to this Company Record